Investigator
Mengling Liu
NEW YORK UNIVERSITY SCHOOL OF MEDICINE · funded by NIOSH, NIEHS
- Companies
- 1
- Grants
- 2
- Non-dilutive funding
- $881k
- First award
- Apr 9, 2021
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Jul 1, 2023.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- Pharmasaga Co. Ltd.88momentum
OncologyPhase I
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- U01
Complex WTC Exposures Impacting Persistent Large and Small Airflow Limitation and Vulnerable Subgroups in the WTC Survivor Population
$500kJul 1, 2023NIOSHNEW YORK UNIVERSITY SCHOOL OF MEDICINENIH RePORTER · 11074513 (opens the source filing in a new tab)
- R01
SEMIPARAMETRIC METHODS FOR MODELING OF TIME-DEPENDENT ENVIRONMENTAL EXPOSURES
$381kApr 9, 2021NIEHSNEW YORK UNIVERSITY SCHOOL OF MEDICINENIH RePORTER · 11017721 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources